PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29156556-7	2017	Furthermore, the mTORC1 and Wnt/beta-catenin pathway-specific antagonist rapamycin and XAV939 (3,5,7,8-tetrahydro-2-[4-(trifluoromethyl)]-4H -thiopyrano[4,3-d]pyrimidin-4-one) both suppressed the proliferation of IPEC-J2 cells overexpressing CDX2, and that the combination of rapamycin and XAV939 had an additive effect.	XAV939	87-93	caudal type homeobox 2	Sus scrofa	242-246	
29156556-8	2017	Regardless of whether the cells were treated with rapamycin or XAV939 alone or in combination, both mTORC1 and Wnt/beta-catenin pathways were down-regulated, accompanied by a decrease in CDX2 expression.	XAV939	63-69	caudal type homeobox 2	Sus scrofa	187-191